Data Foundry

Drug recalls 2017

Albuterol Sulfate Inhalation Solution — Class III drug recall D-1039-2017

Terminated recall by Teva Pharmaceuticals USA, reported 2017-08-09, distributed nationwide. Failed Impurities/Degradation Specifications: high out of specification results for related compound D.

Recall numberD-1039-2017
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmTeva Pharmaceuticals USA, North Wales, PA, United States
Recall initiated2017-07-25
Classified2017-07-31
Reported by FDA2017-08-09
Terminated2018-04-26
DistributedNationwide (US)
Quantity401,750 cartons
Reason classesspecification failure
NDC00591-3467-53
Lot numbers01/18, 06/18, 08/17, 09/17, 10/17, 11/17, 12/17, GA60206, GA60207, GA60283, GA60284, GA60378, GA60379, GA60478, GA60491, GA60615, GA60616, GA60719, GA60720, GA60721, GA60749, GA60750, GA60751, GA70001, GA70031, GA70046, GA70047, GA70074, GA70075

Product

Albuterol Sulfate Inhalation Solution, 0.021% (0.63 mg/3mL), packaged in 5 pouches of 5 x 3mL Sterile Unit-Dose Vials For Inhalation per carton, Rx only, Mfd. for: Watson Laboratories, Inc., Corona, CA 92880; Mfd. by: Cipla Ltd., Verna, Goa INDIA, NDC 0591-3467-53.

Reason for recall

Failed Impurities/Degradation Specifications: high out of specification results for related compound D.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1039-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.